Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis

Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis

Introduction Different COVID-19 vaccines are being utilized as boosters. This systematic review and meta-analysis aims to evaluate the reactogenicity of COVID-19 vaccines given as booster doses, according to vaccine type, dose, timing, participant characteristics and primary immunization regimen rec...

Full description

Bibliographic Details
Main Authors:	Alberto San Francisco Ramos, Carolina Liu Sanchez, Tatiana Bovill Rose, David Smith, Natasha Thorn, Eva Galiza, Thahmena Miah, Jennifer Pearce, Cecilia Hultin, Catherine Cosgrove, Yingfen Hsia, Paul T. Heath
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Expert Review of Vaccines
Subjects:	Systematic review meta-analysis COVID-19 vaccine boosters reactogenicity adverse events
Online Access:	https://www.tandfonline.com/doi/10.1080/14760584.2024.2315089

Similar Items

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study
by: Asmik Asatryan, et al.
Published: (2021-03-01)

REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL
by: V.K. Tatochenko, et al.
Published: (2006-07-01)

REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL
by: V.K. Tatochenko, et al.
Published: (2006-01-01)

No significant influence of pre-vaccination antipyretic use on specific antibody response to a BNT162b2 vaccine booster against COVID-19
by: Naoki Tani, et al.
Published: (2022-12-01)

Association between Adverse Reactions and Humoral Immune Response No Longer Detectable after BNT162b2 Booster Vaccination
by: Stilla Bauernfeind, et al.
Published: (2022-09-01)

The Relationship between Immunogenicity and Reactogenicity of Seasonal Influenza Vaccine Using Different Delivery Methods
by: Daniel J. Gromer, et al.
Published: (2024-07-01)

Safety and immunogenicity of a booster dose of S-268019-b: Interim findings of a Phase 3, open-label clinical study in Japan
by: Takuhiro Sonoyama, et al.
Published: (2023-12-01)

Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses
by: Giorgia Tiozzo, et al.
Published: (2023-12-01)

Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines
by: Matthew D. Rousculp, et al.
Published: (2024-07-01)

COMPARISON OF REACTOGENICITY AND IMMUNOGENICITY OF LIVE VACCINES AGAINST INFECTIOUS LARYNGOTRACHEITIS
by: S. A. Pokhvalny, et al.
Published: (2018-05-01)

REACTOGENITY OF TICK-BORNE ENCEPHALITIS VACCINE ENCEPUR ADULT AND IMMUNE RESPONSE
by: G. N. Leonova, et al.
Published: (2014-07-01)

Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials
by: Romulo Colindres, et al.
Published: (2020-11-01)

Immunogenicity and Reactogenicity in Q Fever Vaccine Development
by: Alycia P. Fratzke, et al.
Published: (2022-05-01)

Reduction of adverse reactions and correlation between post-vaccination fever and specific antibody response across successive SARS-CoV-2 mRNA vaccinations
by: Naoki Tani, et al.
Published: (2024-06-01)

Editorial: Non-reactogenic vaccines against Q-fever
by: Anthony E. Gregory, et al.
Published: (2023-05-01)

THE EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF THE POLYSACCHARIDE PNEUMOCOCCAL VACCINE DURING THE IMMUNIZATION OF HEALTH CARE WORKERS
by: I. V. Feldblum, et al.
Published: (2014-06-01)

Methods for predicting vaccine immunogenicity and reactogenicity
by: Patrícia Gonzalez-Dias, et al.
Published: (2020-02-01)

Prevalence of COVID‐19 vaccine reactogenicity among Bangladeshi physicians
by: Md. Anwarul Azim Majumder, et al.
Published: (2022-06-01)

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
by: Waleed H. Mahallawi, et al.
Published: (2021-12-01)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
by: Oleguer Parés-Badell, et al.
Published: (2022-07-01)

A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants
by: Vibhu Kanchan, et al.
Published: (2020-03-01)

Reactogenicity of various COVID-19 vaccination regimens
by: O. M. Drapkina, et al.
Published: (2023-01-01)

Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
by: Ting-Yun Lin, et al.
Published: (2022-08-01)

From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics
by: Tetiana Korzun, et al.
Published: (2023-07-01)

Cohort event monitoring for safety signal detection in adult individuals 18 years and above after immunisation with coronavirus disease 2019 vaccines in Nigeria
by: Akinsanya O Osibogun, et al.
Published: (2023-01-01)

Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries
by: Marina George, et al.
Published: (2023-01-01)

Effects of Short-Term Corticosteroid Use on Reactogenicity and Immunogenicity of the First Dose of ChAdOx1 nCoV-19 Vaccine
by: Jinyoung Yang, et al.
Published: (2021-09-01)

Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
by: Valentina Mazzotta, et al.
Published: (2024-12-01)

Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years
by: Gili Joseph, et al.
Published: (2022-11-01)

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
by: Stilla Bauernfeind, et al.
Published: (2021-09-01)

Vaccine Side Effects in Health Care Workers after Vaccination against SARS-CoV-2: Data from TüSeRe:exact Study
by: Alan Bareiß, et al.
Published: (2022-12-01)

Reactogenicity, safety and immunological efficacy of the live, pentavalent rotavirus vaccine in childhood immunization (results of the multicenter clinical trial)
by: Irina V. Feldblium, et al.
Published: (2020-09-01)

Immunogenicity and reactogenicity following MMR vaccination in 5–7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infantsResearch in context
by: Dorthe Maria Vittrup, et al.
Published: (2024-02-01)

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
by: Nijalingappa K. Kalappanavar, et al.
Published: (2022-11-01)

Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females
by: Tao Haskins-Coulter, et al.
Published: (2017-06-01)

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review
by: Yam B. Limbu, et al.
Published: (2023-03-01)

Immunogenicity and Reactogenicity of the Booster Dose of COVID-19 Vaccines and Related Factors: A Panel Study from the General Population in Serbia
by: Maja Stosic, et al.
Published: (2022-05-01)

Adverse Reactions after the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine among Medical School Residents in a Regional Reference University Hospital in Italy
by: Alborz Rahmani, et al.
Published: (2022-10-01)

Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey
by: Alexander G. Mathioudakis, et al.
Published: (2021-03-01)

Short Term Reactogenicity of a Triple Diphtheria-Tetanus-Whole Cell Pertussis Vaccine in Iranian Infants
by: S Zarei, et al.
Published: (2009-03-01)